已收盤 09-19 16:00:00 美东时间
+0.160
+0.31%
LivaNova PLC (NASDAQ:LIVN) was upgraded to Outperform at Baird on improving visibility and the company’s confidence on upside revenue for the coming years. With a price target of $66, Baird says, “Upg...
09-17 21:20
LivaNova ( ($LIVN) ) has provided an announcement. LivaNova PLC has announced t...
09-10 21:28
LivaNova PLC press release (NASDAQ:LIVN): Q2 Non-GAAP EPS of $0.93 beats by $0.15. Revenue of $318.6M (+8.4% Y/Y) beats by $13.36M. FY 2024 Guidance LivaNova now expects revenue for full-year 2024 to ...
07-31 18:05
Baird analysts outlined stocks within medical technology where they see an upside during the second quarter’s earnings. Healthcare and med-tech has underperformed the broader market year-to-date, but ...
07-18 23:34
Seeking Alpha analysts ranks the highest rated growth stocks, which are companies anticipated to growth a significant pace compared to the average growth for the market. The list is generated by Seeki...
07-13 01:02
Mizhuo picks Axsome Therapeutics (AXSM), Wave Life Sciences (WVE), Arcutis Biotherapeutics (ARQT), LivaNova (LIVN) and Humana (HUM) as July’s top picks. Mizhuo put out a list of its top stock picks fo...
07-04 01:34
NEW YORK, June 24, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of LivaNova PLC ("LivaNova" or the "Company") (NASDAQ: LIVN). Such investors are advised ...
06-25 05:48
The latest announcement is out from LivaNova (LIVN). LivaNova PLC successfully ...
06-13 05:00
Analyst Anthony Petrone from Mizuho Securities maintained a Buy rating on LivaN...
06-12 15:55
Shares of LivaNova (NASDAQ:LIVN) fell 11% in late morning trading Thursday after the company reported that the unipolar patient cohort of its RECOVER study for its VNS Therapy product for treatment-re...
06-06 23:37